Short answer
Tyra Biosciences, Inc. (TYRA) filed an 8-K current report with the SEC on April 2, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Julia Rueb appointed principal accounting officer effective April 1, 2026.
Tyra Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Julia Rueb appointed principal accounting officer effective April 1, 2026
- Alan Fuhrman remains principal financial officer and Chief Financial Officer
- Rueb brings internal continuity, serving as Vice President, Finance since January 2024
- CPA with prior public life sciences audit experience at Ernst & Young
- No disclosed family relationships with directors or executive officers
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tyra Biosciences, Inc. 8-K filings
Get the next TYRA 8-K as it lands
Follow TYRA for push alerts, or ask the research agent what this filing means.